Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation
Andrea Adrados, Juan Pérez-Fernández, Roberto García-Vicente, Alba Garrote-de-Barros, Joaquín Martinez-Lopez, María Linares, María Hernández-Sánchez · 2026
Read Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation by Andrea Adrados, Juan Pérez-Fernández, Roberto García-Vicente, Alba Garrote-de-Barros, Joaquín Martinez-Lopez, María Linares, María Hernández-Sánchez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318670.txt.
Description
Andrea Adrados and colleagues review, in 2026, ways to make immunotherapy work better in two blood cancers. The diseases are multiple myeloma and chronic lymphocytic leukaemia. First-line treatments often work at first, then resistance grows. New immune treatments show promise but do not last for everyone.
The review covers pairing new immune drugs with standard treatments. Checkpoint inhibitors, CAR T-cells, and bispecific antibodies all feature. It also examines the gut microbiota and its effect on treatment response. Microbe balance may shape disease biology and drug success. The authors close with current challenges and future directions. Their goal is longer, safer responses for more patients.
Catalog record
| CREATOR | Andrea Adrados, Juan Pérez-Fernández, Roberto García-Vicente, Alba Garrote-de-Barros, Joaquín Martinez-Lopez, María Linares, María Hernández-Sánchez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 97455 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |